Crestron’s Touchless Meetings Were Ahead of their Time Until COVID Made Them Essential

 

Key Points:

  • Crestron has seen a major shift in room designs as well as video conferencing technologies.
  • As companies redesign their entire office space to accommodate more virtual elements, Crestron has still been able to ship products to their customers to help enable this transformation.
  • Supply chain issues have caused integrators to plan their installments around what is available instead of what the simplest set up might be.

Commentary:

We are back from InfoComm 2021! This year, our MarketScale Media Center was the hub for important trends and technologies shaping not only AV, but the way we work, collaborate, and communicate. But that doesn’t mean we don’t have more interviews to drop. While Tyler Kern was at the show, he sat down with Richard Sasson, the Global Director of Training at Crestron Electronics, about the concept of “no-touch meetings.” It was a concept that the company had been touting for many years before the pandemic, but the demand wasn’t there…until it was, skyrocketing last year.

Abridged Thoughts:

One of the really important things that came out of the pandemic was something that we have been working on for many years and have been promoting for many years – the concept of a no touch meeting.

And everyone was like: “Yeah, yeah, yeah, yeah, no touch meeting, it’s a nice, kind of cool idea.” Then the pandemic hit and they went: “Wait, you guys do no touch meeting. What does that mean? How come no one knows about?”

What we had been doing for many years was now something people really wanted to widely adopt. We’ve seen a huge, as everybody in the industry has, shift in meeting room designs and shift in video conferencing technology to more unified communications technology.

And we’re now selling (of course, we have been for many years) the concept of Teams rooms and Zoom rooms and items along those lines. And that part of our market has gone through the roof, which has brought with it as part of the industry has evolved and office space is gone a whole new direction, there’s a demand that a year and a half ago wasn’t there a year and a half ago.

More Stories Like This:

InfoComm 2021: Can AI Take the Artificial Out of the Office Experience?

InfoComm 2021: The Real Impact of the Pandemic on AV’s Work and Workforce

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More